Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis

@article{Asgary2019EffectOR,
  title={Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis},
  author={Sedigheh Asgary and Raheleh Karimi and Saeideh Momtaz and Rozita Naseri and Mohammad Hosein Farzaei},
  journal={Reviews in Endocrine and Metabolic Disorders},
  year={2019},
  volume={20},
  pages={173-186}
}
We summarized 16 controlled studies and evaluated the correlation of resveratrol supplementation with metabolic parameters such as the body weight, waist circumference (WC), systolic blood pressure (sbp), HDL, total cholesterol, triglyceride and glucose levels. This meta-analysis was carried out to determine the association between the resveratrol intake with metabolic parameters in metabolic syndrome patients. PubMed, Scopus, Cochrane and Google Scholar were searched from inception to December… Expand
The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials.
TLDR
Current evidence does not support supplementation with resveratrol for the management of cardiometabolic risk factors in patients with T2D, MetS, and NAFLD. Expand
Usefulness of resveratrol supplementation in decreasing cardiometabolic risk factors comparing subjects with metabolic syndrome and healthy subjects with or without obesity: meta-analysis using multinational, randomised, controlled trials
TLDR
Despite some heterogeneity in the populations, RES supplementation seems to improve cardiometabolic health, decreasing some risk factors associated with CVD. Expand
Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
TLDR
CR diet with moderate weight loss has favorable effects on NAFLD, and resveratrol supplementation induced weight loss but failed to mimic other aspects of CR diet. Expand
Resveratrol and Markers of Polycystic Ovary Syndrome: a Systematic Review of Animal and Clinical Studies
TLDR
The current literature is limited to conclude the beneficial effects of resveratrol on the management of PCOS, although, according to the promising results of the animal studies and limited RCTs, resver atrol might be an effective phytochemical in PCOS control, especially regarding hormonal and reproductive abnormalities. Expand
Pathogenetic Mechanisms of Metabolic Syndrome Development and its Correction with Grape-Derived Stilbene Concentrate
TLDR
The treatment of experimental MetS with GDSC prevented associated inflammatory reactions and protected the heart and blood vessels from damage. Expand
Comparison of Resveratrol Supplementation and Energy Restriction Effects on Sympathetic Nervous System Activity and Vascular Reactivity: A Randomized Clinical Trial
TLDR
RSV does not improve cardiometabolic risk factors, sympathetic activity, and endothelial function, and ER decreases plasma NA and waist circumference as well as improves blood lipids, but does not modify endothelialfunction. Expand
Anti-inflammatory and antidiabetic effects of grape-derived stilbene concentrate in the experimental metabolic syndrome
TLDR
The use of the GDSC had positive dynamics in carbohydrate and lipid levels, inflammatory marker, also prevented associated inflammation and heart damage. Expand
Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy
TLDR
The preliminary findings suggest that SIRT1 interacted with inflammatory cytokines associated with MetS in schizophrenia patients treated with SGA monotherapy, and was significantly correlated with diastolic blood pressure, triglyceride, and high-density lipoprotein cholesterol in schizophrenia Patients. Expand
Nutrition, Bioenergetics, and Metabolic Syndrome
TLDR
Clinical and experimental data extracted from in vitro animal and cell models support the idea that a balanced diet, in a healthy lifestyle context, promotes proper bioenergetic and mitochondrial function, becoming the best medicine to prevent the onset and progression of MetS. Expand
Polyphenol-Rich and Alcoholic Beverages and Metabolic Status in Adults Living in Sicily, Southern Italy
TLDR
Current scientific evidence suggests that such beverages may play a role on cardio-metabolic risk factors, especially when consumed within the context of a dietary pattern characterized by an intake of a plurality of them, however, these associations might be mediated by an overall healthier lifestyle. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 75 REFERENCES
Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.
TLDR
The present meta-analysis indicates that resveratrol consumption significantly decreases the SBP level at the higher dose, while resver atrol has no significant effects on DBP levels. Expand
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.
TLDR
Resveratrol significantly improves glucose control and insulin sensitivity in persons with diabetes but does not affect glycemic measures in nondiabetic persons. Expand
Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials.
TLDR
Overall, resveratrol supplementation had no significant effect on any of the lipid parameters assessed and current evidence suggests that mechanisms other than hypolipidemic effects account for the established cardioprotective properties of resver atrol. Expand
Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial
TLDR
150 mg of daily resveratrol intake for 4 weeks does not change metabolic risk markers related to cardiovascular health in overweight and slightly obese men and women and effects on glucose metabolism warrant further study. Expand
No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial
TLDR
RSV treatment did not improve inflammatory status, glucose homeostasis, blood pressure, or hepatic lipid content in middle-aged men with MetS, and RSVhigh significantly increased total cholesterol, LDL cholesterol, and fructosamine levels compared with placebo. Expand
Usefulness of resveratrol supplementation in decreasing cardiometabolic risk factors comparing subjects with metabolic syndrome and healthy subjects with or without obesity: meta-analysis using multinational, randomised, controlled trials
TLDR
Despite some heterogeneity in the populations, RES supplementation seems to improve cardiometabolic health, decreasing some risk factors associated with CVD. Expand
Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
TLDR
CR diet with moderate weight loss has favorable effects on NAFLD, and resveratrol supplementation induced weight loss but failed to mimic other aspects of CR diet. Expand
Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion.
TLDR
Administration of resveratrol significantly decreases weight, BMI, fat mass, WC, AUC of insulin, and total insulin secretion. Expand
Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study
TLDR
It is suggested that short-term resveratrol supplementation at doses of 300mg/day and 1000mg/ day does not adversely affect blood chemistries and is well tolerated in overweight, older individuals. Expand
Anthocyanins in the Management of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
TLDR
The intake of ANT-rich supplements should be considered due to their plausible ability for prevention and management of MetS, and randomized double-blind clinical trials are obligatory for evaluating the bioefficacy and pharmacological mechanisms of ANTs and their pharmaceutical formulations in patients with MetS. Expand
...
1
2
3
4
5
...